Tanabe Kazuhiro, Zheng Qianqian, Zhang Xuguang, Tanaka Naoki, Hayashi Chihiro, Yokota Asaka, Otsuka Rina, Katahira Tomoko, Kohjima Motoyuki, Nakamuta Makoto
Medical Solution Promotion Department, Medical Solution Segment, LSI Medience Corporation, 3-30-1, Shimura, Itabashi, Tokyo, 174-8555, Japan.
Department of Metabolic Regulation, Shinshu University School of Medicine, Matsumoto, Japan.
Sci Rep. 2025 Jul 2;15(1):22797. doi: 10.1038/s41598-025-04670-5.
Diabetic cardiomyopathy (DCM) is a leading cause of mortality in patients with diabetes, highlighting the need to better understand its mechanisms for effective treatment. The primary pathogenic mechanism of DCM is mitochondrial dysfunction associated with increased oxidative stress; however, the exact reasons why diabetes triggers this condition remain unclear. An 8-week-old male Zucker diabetic fatty rat model of type 2 diabetes was used for this analysis. Metabolomic and lipidomic analyses were conducted not only in the heart but also across several other organs to elucidate metabolic changes specifically occurring in the heart. Proteomic analysis and gene expression profiling using qPCR were performed on the heart to achieve a comprehensive understanding. The marked reduction of the radical scavenger carnosine and the increased gene expression of catalase and Sestrin2 in the heart suggested elevated oxidative stress. A decrease in Complex I proteins and an increase in Complex I gene expression indicate rapid mitochondrial turnover in diabetic cardiomyocytes. Additionally, the increased expression of adenylate kinase and xanthine oxidoreductase accelerated the adenosine monophosphate degradation pathway, leading to reactive oxygen species generation. These insights into mitochondrial dysfunction and metabolic disturbances could inform the development of innovative therapies and pharmacological approaches for managing diabetic heart failure.
糖尿病性心肌病(DCM)是糖尿病患者死亡的主要原因,这凸显了更好地了解其发病机制以进行有效治疗的必要性。DCM的主要致病机制是与氧化应激增加相关的线粒体功能障碍;然而,糖尿病引发这种病症的确切原因仍不清楚。本分析使用了8周龄的2型糖尿病雄性Zucker糖尿病脂肪大鼠模型。不仅对心脏,还对其他几个器官进行了代谢组学和脂质组学分析,以阐明心脏中具体发生的代谢变化。对心脏进行了蛋白质组学分析和使用qPCR的基因表达谱分析,以获得全面的了解。心脏中自由基清除剂肌肽的显著减少以及过氧化氢酶和Sestrin2基因表达的增加表明氧化应激升高。复合体I蛋白的减少和复合体I基因表达的增加表明糖尿病心肌细胞中线粒体周转加快。此外,腺苷酸激酶和黄嘌呤氧化还原酶表达的增加加速了单磷酸腺苷降解途径,导致活性氧的产生。这些关于线粒体功能障碍和代谢紊乱的见解可为开发治疗糖尿病性心力衰竭的创新疗法和药理学方法提供参考。
Cardiovasc Diabetol. 2025-7-3
Cell Mol Life Sci. 2025-6-25
Front Biosci (Landmark Ed). 2025-6-17
J Cardiovasc Dev Dis. 2023-9-6
Biochem Biophys Rep. 2023-4-25
Int J Mol Sci. 2022-7-16
Front Cardiovasc Med. 2022-3-2